Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Series Introduction: JAK-STAT signaling in human disease
Christian W. Schindler
Christian W. Schindler
Published May 1, 2002
Citation Information: J Clin Invest. 2002;109(9):1133-1137. https://doi.org/10.1172/JCI15644.
View: Text | PDF
Perspective

Series Introduction: JAK-STAT signaling in human disease

  • Text
  • PDF
Abstract

Authors

Christian W. Schindler

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
STAT and JAK structure. The STATs share several conserved domains, inclu...
STAT and JAK structure. The STATs share several conserved domains, including an amino-terminal domain (NH2), a coiled-coil domain, the DNA-binding domain, a linker domain, an SH2 domain, and a tyrosine activation domain (P). The carboxy-terminal transcriptional activation domain is conserved in function, but not in sequence. Likewise, the JAKs share seven regions of high homology, JH1–JH7. JH1 has been shown to encode the kinase. JH2 represents a pseudokinase domain, which appears to regulate JH1 catalytic activity. JH3–JH7 have been implicated in receptor association. See text for details.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts